Meridian Gets FDA Clearance for New Neonatal Saliva CMV Test

World News: . []

CINCINNATI Dec 06 2018 GLOBE NEWSWIRE -- Meridian Bioscience Inc (NASDAQ: VIVO today announced that it has received FDA clearance for its new Alethia CMV Molecular Amplification Test (formerly, the gene brandThis assay is designed to s pecific...

More news and information about Meridian Bioscience Inc.

Published By:

Globe Newswire: 12:30 GMT Thursday 6th December 2018

Published: .

Search for other references to "meridian" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us